baber/WOPTO huggingface dataset:
Patent AT-E465604-T1 (AT)
Inventor: BOEGESKOV-JENSEN TOM
IPC: H04R25/02
Filed: 1999-10-07
Granted: 2010-05-15
Abstract: A hearing aid includes a housing and a hook, the housing defining a top area and a bottom area, a front end and a rear end, and contains a microphone, an amplifier, a receiver, and a battery for power supply, and the hook is attached to the housing and transmits acoustic signals from the receiver into the ear of the user. The housing is provided by two connectable and detachable parts having lines of separation extending at least partly between top and bottom at both sides of the housing between the front end and the rear end, and means are provided in the front part for holding an amplifier circuitry board at one edge.
Patent AT-E332066-T1 (AT)
Inventor: ANTONIO FRANKLIN P
IPC: H04B7/26
Filed: 1999-10-26
Granted: 2006-07-15
Abstract: A detector is used to sample of set of power measurements of a receive signal. The receive signal may comprise one or more signals from remote users as well as interference. A variance of the set of power measurements is also determined. The variance is compared to an overload threshold value. If the variance exceeds the overload threshold value, for some period of time, the system is declared to be operating at a potentially unstable point. In this state, future connection originations are denied.
Patent DE-921726-T1 (DE)
Inventor: YOUNG COLIN LESLIE
IPC: A01N25/00
Filed: 1997-01-22
Abstract: A method of preparation of a stomach-action molluscicide comprising a metal complexone as an active ingredient and a carrier therefor, comprising the steps of:  (i) blending the components together to form a blended composition; (ii) heating the blended composition for about 1 to 5 minutes in the presence of steam at an ambient temperature of between about 80 DEG C and 100 DEG C; (iii) maintaining the composition at the ambient temperature between about 10 and 30 seconds; and (iv) forming the blended composition into one or more pellets.  <??>Preferably, the metal complexone is ÄFe(OH)EDTAÜ<2->.
Patent ES-2029445-T1 (ES)
Title: Cabeza escariorada.
IPC: B23Q11/00
Filed: 1991-05-14
Abstract: LA PRESENTE INVENCION SE REFIERE A UNA CABEZA DE MANDRILAR CONSTITUIDA POR UN CUERPO (1) DOTADO DE UN PISTON RADIAL (2) DE RECEPCION DE UNA HERRAMIENTA DE MANDRILAR (3) AJUSTADA MEDIANTE UN TORNILLO (4), SIENDO AJUSTABLE DICHO PISTON (2) EN POSICION MEDIANTE UN TORNILLO MICROMETRICO (5), CARACTERIZADA EN QUE EL CUERPO (1) ESTA PROVISTO, ADEMAS, DE UN COLISON (6) QUE REALIZA LA GUIA, LA ORIENTACION Y UN TOPE DE FIN DE RECORRIDO PARA EL PISTON (2) DE RECEPCION DE LA HERRAMIENTA DE MANDRILAR (3) Y DE UN DISPOSITIVO (7) DE EQUILIBRADO DE PORTACEBOS INDEPENDIENTES (8 Y 9).
Patent ES-2056036-T1 (ES)
Title: Granulados colorantes fluidos, quimicamente resistentes, obtencion y usos de los mismos.
Inventor: THOMETZEK PETER DR
IPC: C09C3/04
Filed: 1993-12-10
Abstract: LA INVENCION SE REFIERE A UN GRANULADO COLORANTE RESISTENTE QUIMICAMENTE, CAPAZ DE FLUIR, QUE SE FABRICA POR GRANULACION DE SU COMPOSICION, ASI COMO SU EMPLEO.
Patent CY-1107094-T1 (CY)
Title: Φθοροϋποκατεστημενη ωμεγα-καρβοξυαρυλ διφαινυλ ουρια για τη θεραπεια και προληψη ασθενειων και καταστασεων
Inventor: DUMAS JACQUES
IPC: A61K31/675
Filed: 2007-12-14
Abstract: Μία ένωση του τύπου (Ι): (Ι) Αλατα αυτής, προφάρμακα αυτής, μεταβολίτες αυτής, φαρμακευτικές συνθέσεις που περιέχουν μία τέτοια ένωση και χρήση μιας τέτοιας ένωσης και συνθέσεων για να θεραπεύονται ασθένειες που προκαλούνται από raf, VEGFR, PDGFR, p38 και flt-3.
Patent CY-1110783-T1 (CY)
Inventor: KIM KYUNG JIN
IPC: C12N5/20
Filed: 2010-08-30
Abstract: The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Patent CY-1112249-T1 (CY)
Inventor: STEVENS PAUL THEODOOR AGNES
IPC: A61P31/18
Filed: 2011-08-10
Abstract: The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.
Patent CY-1112529-T1 (CY)
Title: Βιομηχανικη μεθοδος για τη συνθεση 17-ακετοξυ-11β-[4-(διμεθυλαμινο)-φαινυλο]-21-μεθοξυ-19-νορπρεγνα-4,9-διεν-3,20-διονης και των ενδιαμεσων ενωσεων-κλειδιων της μεθοδου
Inventor: Bódi József 
IPC: C07J51/00
Filed: 2011-12-14
Abstract: Η παρούσα εφεύρεση σχετίζεται με μια μέθοδο σύνθεσης της γνωστής 17-ακετοξυ-11β-[4-(διμεθυλαμινο)-φαινυλο]-21-μεθοξυ-19-νορπρεγνα-4,9-διεν-3,20-διόνης (αργότερα CDΒ-4124) του τύπου (Ι) από 3,3-[1,2-αιθανδιυλ-δις(οξυ)]-οιστρ-5(10),9(11)-διεν-17-όνη του τύπου (II). Η ένωση CDΒ-4124 ανήκει στην ομάδα των αντι-ορμονών. Η μέθοδος σύμφωνα με την εφεύρεση είναι η παρακάτω: i) σχηματισμός εποξειδίου πάνω στον διπλό δεσμό στη θέση 5(10) της 3,3-[1,2-αιθανοδιυλ-δις(οξυ)]-οιστρ-5(10),9(11)-διεν-17-όνης του τύπου (II) με υπεροξείδιο του υδρογόνου· ii) προσθήκη υδροκυανίου που σχηματίζεται επί τόπου στη θέση 17 της λαμβανόμενης 5,10α-εποξυ-3,3-[1,2-αιθανοδιυλο-δις-(οξυ)]-5α-οιστρ-9(11)-εν-όνης του τύπου (III) iii) σιλυλίωση της υδροξυλομάδας στη θέση 17 του σχηματιζόμενου 5,10α-εποξυ-3,3-[1,2-αιθανοδιυλο-δις(οξυ)] -17α-υδροξυ-5α-οιστρ-9(11)-εν-17β-καρβονιτριλίου του τύπου (IV) με τριμεθυλο χλωροσιλάνιο· iv) αντίδραση του λαμβανόμενου 5,10α-εποξυ-3,3-[1,2-αιθανοδιυλο-δις(οξυ)]-17-τριμεθυλο-σιλυλο-οξυ]-5α-οιστρ-9(11)-εν-17β-καρβονιτριλίου του τύπου (V) με 4-(διμεθυλαμινο)-φαινυλο μαγνήσιο βρωμίδιο αντιδραστήριο Grignard παρουσία CuCl (αντίδραση Teutsch)· v) σιλυλίωση της υδροξυλομάδας στη θέση 5 του σχηματιζόμενου 11β-[4-(διμεθυλο-αμινο)-φαινυλο]-3,3-[1,2-αιθανοδιυλο-δις(οξυ)]-5-υδροξυ-17α-[τριμεθυλοσιλυλο-(οξυ)]-5α-οιστρ-9-εν-17β-καρβονιτριλίου του τύπου (VI) με τριμεθυλο χλωροσιλάνιο· νi) αντίδραση του λαμβανόμενου 11β-[4-(διμεθυλαμινο)-φαινυλο]-3,3-[1,2-αιθανοδιυλο-δις(οξυ)]-5,17α-δις-[τριμεθυλοσιλυλο-(οξυ)]-5α-οιστρ-9-εν-17β-καρβονιτριλίου του τύπου (VII) με διισοβουτυλο αργίλιο υδρίδιο και στη συνέχεια προσθήκη οξέος στο μίγμα αντίδρασης· vii) μεθοξυ-μεθυλίωση της λαμβανόμενης 11β-[4-διμεθυλαμινο)-φαινυλο]-3,3-[1,2-αιθανοδιυλο-δις(οξυ)]-5,17α-δις-[τριμεθυλοσιλυλο-(οξυ)]-5α-οιστρ-9-εν-17β-καρβαλδεϋδης του τύπου (VII) με μεθοξυ-μεθυλο αντιδραστήριο Grignard που σχηματίζεται επί τόπου, με παράλληλη υδρόλυση των τριμεθυλοσιλυλο προστατευτικών ομάδων· viii)
Patent CY-1112212-T1 (CY)
Title: Νεα σκευασματα πεπτιδιων που σχετιζονται με ογκους τα οποια συνδεονται σε μορια του αντιγονου ανθρωπινων λευκοκυτταρων (hla) ταξης i ή ii για εμβολια
Inventor: LEWANDROWSKI PETER
IPC: A61P35/00
Filed: 2012-01-03
Abstract: Η παρούσα εφεύρεση αφορά νέα σκευάσματα πεπτιδίων που σχετίζονται με όγκους τα οποία συνδέονται σε μόρια του αντιγόνου ανθρώπινων λευκοκυττάρων (HLA) Τάξης I ή II ως εμβόλια για χρήση σε ανοσοθεραπευτικές μεθόδους. Συγκεκριμένα, η παρούσα εφεύρεση σχετίζεται με σκευάσματα για την ανοσοθεραπεία του καρκίνου, και συγκεκριμένα καρκίνο του νεφρού και του εγκεφάλου, και συγκεκριμένα γλοίωμα, ειδικότερα γλοιοβλάστωμα καρκίνου. Η παρούσα εφεύρεση αφορά επιπλέον συνθέσεις εμβολίων για να επιφέρουν αντικαρκινικές ανοσοαπαντήσεις.
Patent CY-1113625-T1 (CY)
Title: Μεθοδος για την παραγωγη συμπυκνωμενων παραγωγων της πιπεραζιν-2-ονης καθως και ενδιαμεσα προϊοντα της μεθοδου
Inventor: DURAN ADIL
IPC: C07D475/00
Filed: 2012-12-12
Abstract: Η εφεύρεση αφορά μια μέθοδο για την παραγωγή συμπυκνωμένων παραγώγων της πιπεραζιν-2-όνης του γενικού τύπου (I), όπου οι ρίζες R1 έως R5, A1 και Α2 έχουν τη σημασία που αναφέρεται στις αξιώσεις και στην περιγραφή, ιδιαιτέρως την παραγωγή παραγώγων της 7,8-διυδρο-5Η-πτεριδιν-6-όνης.
Patent CY-1116071-T1 (CY)
Title: Εξενδινη για θεραπευτικη αγωγη διαβητη και μειωση σωματικου βαρους
Inventor: FINEMAN MARK
IPC: A61K38/26
Filed: 2015-03-02
Abstract: Παρέχονται μέθοδοι για μείωση σωματικού βάρους, αλλαγή σωματικής σύστασης, θεραπευτική αγωγή διαβήτη, μείωση HbA1c και μείωση μέσης ημερήσιας γλυκόζης αίματος χρησιμοποιώντας εξενδίνες, αγωνιστές εξενδίνης ή αγωνιστικά ανάλογα εξενδίνης.
Patent CY-1116542-T1 (CY)
Title: Νεα παραγωγα (συμπυκνωμενης ετεροκυκλο-πιπεριδινης)-(πιπεραζινυλ)-1-αλκανονης ή (συμπυκνωμενης ετεροκυκλο-πυρρολιδινης)-(πιπεραζινυλ)-1-αλκανονης, και χρηση αυτων ως αναστολεων p75
Inventor: BARONI MARCO
IPC: C07D495/04
Filed: 2015-07-01
Abstract: Η εφεύρεση αφορά παράγωγα (συμπυκνωμένης ετεροκυκλο-πιπεριδίνης)-(πιπεραζινυλ)-1-αλκανόνης και (συμπυκνωμένης ετεροκυκλο-πυρρολιδίνης)-(πιπεραζινυλ)-1-αλκανόνης του γενικού τύπου (Ι), όπου τα A, W, n, και R2 είναι όπως ορίζονται στην αξίωση 1, καθώς και τη διεργασία παρασκευής αυτών και την εφαρμογή τους στη θεραπευτική.
Patent CY-1120381-T1 (CY)
Title: Μεθοδος για την αγωγη και τη θεραπεια της λεϊσμανιασης δια της χρησεως φεξινιδαζολης
Inventor: POLLMEIER MATTHIAS
IPC: A61P33/02
Filed: 2018-07-03
Abstract: Η παρούσα εφεύρεση περικλείει μεθόδους χρήσεως φεξινιδαζόλης για την αγωγή και την εξάλειψη και/ή τη θεραπεία μολύνσεως L. infantum σε κυνοειδή.
Patent CY-1120812-T1 (CY)
Title: Υποκατεστημενα παραγωγα αζασπειρο(4.5)δεκανιου
Inventor: WEGERT ANITA
IPC: A61K31/403
Filed: 2018-09-04
Abstract: Η παρούσα εφεύρεση αφορά υποκατεστημένα σπειροκυκλικά παράγωγα κυκλοεξανίου τα οποία παρουσιάζουν συγγένεια για τον υποδοχέα μ-οπιοειδών και/ή τον υποδοχέα ORL1, μεθόδους για την παραγωγή αυτών, φάρμακα τα οποία περιέχουν τις ενώσεις αυτές και τη χρήση των ενώσεων αυτών για την παρασκευή φαρμάκων.
Patent CY-1121498-T1 (CY)
Title: Ενδoγαστρικο μπαλονι
Inventor: KIERATH THOMAS
IPC: A61F5/00
Filed: 2019-04-02
Abstract: Ένα ενδογαστρικό μπαλόνι (10) για χρήση στο στομάχι που περιλαμβάνει ένα σφραγισμένο δοχείο και διαχωρισμένες επεκτάσιμες ουσίες αφρισμού εντός του σφραγισμένου δοχείου, όπου οι ουσίες είναι προσαρμοσμένες για να επεκταθούν και να διογκωθούν σε έναν αφρό όταν αναμιγνύονται.
Patent CY-1122971-T1 (CY)
Title: Ενωσεις διυδροπυριμιδιν-2-ονης και ιaτρικη χρηση αυτων
Inventor: YOKOTA MASAHIRO
IPC: C07D239/22
Filed: 2020-05-20
Abstract: Μια ένωση του Τύπου [Ι] ή ένα φαρμακευτικά αποδεκτό άλας αυτής: όπου κάθε σύμβολο ορίζεται όπως στην περιγραφή.
Patent HR-P20090260-T1 (HR)
Title: Device for dispensing bark beetle pheromone in a controlled manner
Inventor: BAIER ULF
IPC: A01N25/18
Filed: 2009-05-11
Abstract: The present invention relates to a device in the form of a container made of a polymer material, which container has one or more sealed chambers, each of which comprise a liquid pheromone comprising 2-ethyl-1,6-dioxaspiro[4,4]nonane, methyl 2,4-decadiene-carboxylate and at least one alcohol selected among 2-methylbut-3-en-2-ol and 2-methylbut-3-yn-2-ol, where at least 50% of the area of the walls forming the chambers have a wall thickness in the range of from 0.1 to 1 mm and the polymer material which forms the chamber is at least in those areas an uncoated vinyl acetate/ethylene copolymer with a vinyl acetate content in the range of from 10 to 17% by weight. The invention also relates to a method of combating and for monitoring the swarming behavior of the species Pityogenes chalcographus, generally also referred to as spruce wood engraver or six-dentated bark beetle.
Patent HR-P20110494-T1 (HR)
Title: Profiled metal sheet
Inventor: CHABAS ERIC
IPC: E04D3/35
Filed: 2011-07-04
Abstract: The sheet (1) has an end folded towards an interior of the sheet to form a caisson (2) formed by horizontal and vertical walls, where the sheet is made of steel. The caisson has flanges (3, 4) on the vertical walls, and another end has a rib (5) with flanges (6, 7) that are placed on the vertical walls and placed at a height same as that of the flanges (3, 4). The flanges (5, 6) are separated from a distance equal to a distance separating the flanges (3, 4). The rib has a shape to stack the rib on the caisson, and the flanges (3, 4, 6, 7) have shapes for respective clipping of the flanges. An independent claim is also included for a metal wall comprising profiled metal sheets.
Patent SI-1321139-T1 (SI)
Title: 2-Indanylamino deratives for the therapy of chronic, acute or inflammatory pain
Inventor: PIETRA CLAUDIO
IPC: A61P25/04
Filed: 2001-12-21
Abstract: The present invention relates to the use of 2-indanylamino derivatives for the treatment of chronic pain. In particular, the invention relates to the use of 2-(2-indanylamino)-acetamide for the treatment of neuropathic pain, i.e. the pain associated with postherpetic neuralgia, trigeminal neuralgia, diabetic neuropathy and nerve destruction by the human immunodeficiency virus (HIV).
Patent SI-1694599-T1 (SI)
Title: Method for conversion of hydrocarbons
Inventor: EDWIN EMIL
IPC: D01F9/00
Filed: 2003-11-21
Abstract: Process for the preparation of fibrous carbon which comprises contacting a metallic catalyst with a carbon-containing gas at elevated temperature, characterized in that said catalyst is sponge iron.
Patent SI-3299463-T1 (SI)
Title: Enzymatic encoding
Inventor: FRESKGARD PER-OLA
IPC: C12P19/00
Filed: 2003-10-30
Abstract: Disclosed is a method for obtaining a bifunctional complex comprising a display molecule part and a coding part wherein a nascent bifunctional complex comprising a chemical reaction site and priming site for enzymatic addition of a tag is reacted at the chemical reaction site with one or more reactants, and provided with respective tag(s) identifying the reactant(s) at the priming site using one or more enzymes.
Patent SI-1804764-T1 (SI)
Title: Manufacturing of a rapidly disintegrating presentation starting from a solid powder and a step of freeze drying
Inventor: BAUER KURT HEINZ
IPC: A61K9/00
Filed: 2005-10-27
Abstract: The invention relates to a method of manufacture of fast-disintegrating solid dosage forms, characterized in that one or more structure building components in mixed solid powder form are dosed into cavities of blister packs or moulds, the remaining components dissolved in water dosed and added to the powder to form a moistened, plasticized mass, frozen to below −20° C., and the water sublimed in high vacuum. In this way solid dosage forms are obtained with a similar porous structure as usually result from freeze drying processes, but the process requires much less water, which means considerably less time and less energy.
Patent SI-1856045-T1 (SI)
Title: 1-acetic acid-indole derivatives with pgd2 antagonist activity
Inventor: ARMER RICHARD EDWARD
IPC: A61K31/00
Filed: 2006-03-10
Abstract: Compounds of general formula (I) wherein R1 is halo or cyano; R2 is C1-C4 alkyl; and R3 is phenyl substituted with one or more substituents chosen from C1-C6 alkyl, halo or —SO2(C1-C6 alkyl); or a pharmaceutically acceptable salt, hydrate, solvate, complex or prodrug thereof; are useful in the treatment of diseases and conditions mediated by the action of PGD2 at the CRTH2 receptor.
Patent SI-2144811-T1 (SI)
Title: Aircraft
Inventor: REINHARDT OLIVER
IPC: B64D27/00
Filed: 2008-03-29
Abstract: An aircraft, comprising an internal combustion engine by whose drive power a propeller can be driven, wherein the internal combustion engine cooperates with an electric machine which in a first operating mode is operable as electric motor and in a second operating mode as electric generator.
Patent SI-2574630-T1 (SI)
Title: Antibodies that bind il-4 and/or il-13 and their uses
Inventor: RAO ERCOLE
IPC: C07K16/00
Filed: 2008-10-14
Abstract: The present invention relates to a polyvalent bispecific antibody format which comprises a first polypeptide which is a constant heavy chain and a second polypeptide which is a constant light chain, wherein the first polypeptide is attached to two or more variable domains of a heavy chain and the second polypeptide is attached to two or more variable domains of a light chain. A preferred embodiment of the present invention refers to a tetravalent bispecific tandem immunoglobulin (TBTI). 
The polyvalent bispecific antibodies of the present invention resemble and keep the stability characteristics of an immunoglobulin molecule, expressing the heavy and light chains on two different polypeptides and incorporating the constant heavy regions and the constant light regions in order to stabilize the interaction between the variable heavy and the variable light domains and to force correct pairing of the corresponding VHNL. The present invention further refers to the uses of such polyvalent bispecific antibodies.
Patent TR-200400122-T1 (TR)
Inventor: GUELDALI YALCIN
IPC: F25D17/04
Filed: 2002-09-23
Abstract: A refrigerator control method for a refrigerator (1) comprising a fresh food storage compartment (2), a freezer compartment (3), a temperature sensor (4) provided in the freezer compartment (3), a baffle (9) to control the flow of air from the freezer compartment (3) to the fresh food compartment (2), a compressor (5) compressing and circulating the refrigerant, provided with a motor (6), a convertor (7) enabling the operation of the compressor (5) at different numbers of revolution of the motor (6) and a control card (8) enabling said refrigerator to operate as required, which increases the capacity of the compressor (5) by increasing the number of revolutions for the motor (6) depending on the open/closed position of the baffle (9) and on the amount of the temperature increase in the freezer compartment (3) during the operation of said compressor (5), or decreases the capacity of the compressor (5) by decreasing the number of revolutions of the motor (6) depending on the freezer compartment (3) cooling speed when the baffle (9) is open.
Patent TR-200401413-T1 (TR)
Inventor: MAEDA KIMIYA
IPC: C07D277/42
Filed: 2003-08-29
Abstract: A dibenzylamine compound represented by the formula (1)   
wherein R 1  and R 2  are each a C 1-6  alkyl group optionally substituted by halogen atoms and the like; R 3 , R 4  and R 5  are each a hydrogen atom, a halogen atom and the like, or R 3  and R 4  may form, together with carbon atoms bonded thereto, a homocyclic or heterocyclic ring optionally having substituent(s); A is -N (R 7 ) (R 8 ) and the like; ring B is an aryl group or a heterocyclic residue; R 6  is a hydrogen atom, a halogen atom, a nitro group, a C 1-6  alkyl group and the like; n is an integer of 1 to 3, a prodrug thereof and a pharmaceutically acceptable salt thereof show selective and potent CETP inhibitory activity, and therefore, they can be provided as therapeutic or prophylactic agents for hyperlipidemia or arteriosclerosis and the like.
Patent TR-201006273-T1 (TR)
Title: Fotosentezi hızlandıracak bir ürün.
Inventor: SUNDARESAN S
IPC: C05C11/00
Filed: 2008-08-21
Abstract: Fotosentezin verimliliğini artırmak ve böylece ziraat/bahçecilik verimini yükseltmek ve sıvıda çözünebilir toz ve granul şeklindeki fotosentezin hızlandırılmasına yönelik bir ürün elde etmek amacıyla % 5-90 Melamin, % 10-80 Orto Fosforik asit, % 8 potasyum hidroksit, % 8 Sodyum Hidroksit ve maksimum % 30 potasyum sülfat ile biriikte % 5 dietil aminoetil hekzanot, % 10 çinko sülfat monohidrat, % 10 Oktoborat ve % 8-15 ıgsurf 6000 ve % 5-10 nemlendirme maddesi içeren bir bileşimdir.
Patent DE-3588029-T2 (DE)
Inventor: ANTONIO NICHOLAS F D
IPC: F16K15/00
Filed: 1985-08-15
Granted: 1996-02-08
Abstract: In a wound drainage system, blood, water and other body fluids withdrawn from a patient enter a collection chamber (303) through a port (310). A conduit (323) for carrying collected fluids in excess of the capacity of the chamber (303) to a further collection chamber (305) extends from a wall (311) dividing the chambers (303,305) into the chamber (303). The lowermost entrance portion of the conduit (323) is arranged on an imaginary vertical line extending through the centre of gravity of the chamber (303); preferably at a distance d from the uppermost wall (317) defining the chamber (303) where d is given by the formula w/(2 tan  theta ), w being the distance between the closest [at the level of the lowermost entrance portion (333)] of the walls (309,311,319,321) defining the chamber (303) and 90- theta being the maximum angle of rotation about an axis perpendicular to the imaginary vertical axis before spillage occurs. This arrangement will minimise overspill, prior to full capacity caused by tilting the collection chamber (303). <IMAGE>
Patent DE-3588154-T2 (DE)
Inventor: KOHNE DAVID EDWARD
IPC: C12Q1/68
Filed: 1985-06-28
Granted: 1997-08-07
Abstract: A method for the formation of double stranded nucleic acid molecules from separate single stranded nucleic acid molecules in a single phase reaction solution is disclosed wherein the rate of reaction is greatly increased over the rate of reaction at standard reference conditions. The greatly accelerated reaction rate is accomplished through the use of known concentrations of nucleic acid precipitating agents which are added to the reaction solution. Nucleic acid denaturing agents may also be added. The solution so formed is incubated and then assayed for the presence of double stranded nucleic acid molecules.
Patent DE-3751774-T2 (DE)
Inventor: ARACKELLIAN KEVORK
IPC: G06K7/10
Filed: 1987-07-09
Granted: 1996-09-05
Abstract: A preferably hand-held bar code scanner is described in which an invisible laser beam is scanned along a line across the bars of a code in a nominal plane 92 (Fig. 8) in which the bars of said code are disposed; associated with said bar code scanner and preferably integrated with the (hand-held) bar code scanner assembly there is a marker beam system which comprises a source 78 of visible light and associated optics 48 providing a focus of said visible light marker beam along a line 98 generally congruent with the line along which said invisible beam is scanned. For providing said visible light line focus substantially congruent with the line along which the invisible laser beam is scanned, the optics 48 may be an anamorphic or cylindrical lens. The cylindrical lens preferably may serve a double duty in that additionally to providing the visible light line focus of the marker beam system, it may also contribute to suitably shaping the invisible laser beam used for scanning the code bars and/or may also contribute in collecting and focussing the invisible laser beam radiation reflected back from the bar code plane scanned, for detection in the means for reading the bar code.The apparatus disclosed and described thus provides an improved marker beam system which generates a line congruent with the scan path of the invisible laser beam and centered with respect to the length of the scanning path, thus enabling the person handling the bar code reader to reliably and optimally direct the invisible laser scanning beam towards, and into alignment with, the bar code to be read.
Patent DE-3752362-T2 (DE)
Inventor: WOOD HAMISH C S
IPC: A61P35/00
Filed: 1987-09-03
Granted: 2003-11-20
Abstract: The present invention relates to the preparation of substantially pure diastereoisomers of derivatives of tetrahydrofolate and the use of such diastereoisomers. More particularly the present invention provides a process for the preparation of a desired substantially pure (6R or 6S) diastereoisomer of a derivative of tetrahydrofolic acid or salt or ester. The process comprises the steps of: attaching a chiral auxiliary group at either N-5 or N-10 of a mixture of 6R and 6S diastereoisomers of tetrahydrofolic acid, separating the new diastereoisomers, recovering the desired new diastereoisomer (6R or 6S) corresponding to the desired (6R or 6S) diastereoisomer, and converting the substantially pure new diastereoisomer recovered into the corresponding diastereoisomer.